MRI-based BoneMRI image enhancement for visualizing pelvic and cervical, thoracic, lumbar and S1 spinal bone structures with CT-like radiodensity contrast; not for tumor diagnosis or monitoring and not a CT replacement.
Evidence status: each field shows source quality, applicability, and review date. Research pending, information not established in reviewed sources, and vendor documentation pending are distinct outcomes.
Clinical fit
What this tool is for
Start with the authorized purpose, then verify how it fits your service line and reading workflow.
Exact purpose
MRI-based BoneMRI image enhancement for visualizing pelvic and cervical, thoracic, lumbar and S1 spinal bone structures with CT-like radiodensity contrast; not for tumor diagnosis or monitoring and not a CT replacement.
FDA source Exact FDA submission Checked 2026-09-07
Standalone MRI image-processing server that creates an adjunctive bone-visualization series while the original DICOM study remains available for standard interpretation.
FDA source Exact FDA submission Checked 2026-09-07
DICOM BoneMRI images for viewing in a regular DICOM-compatible viewer, with 3D bone morphology, tissue radiodensity and tissue-radiodensity contrast visualized alongside the original images.
FDA source Exact FDA submission Checked 2026-09-07
Not for diagnosis or monitoring of primary or metastatic tumors; BoneMRI images are not intended to replace CT in general. Clinicians must interpret the enhanced images with the original study.
FDA source Exact FDA submission Checked 2026-09-07
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
FDA submission
K233030
FDA source Exact FDA submission Checked 2026-08-31
Use these fields to structure a vendor demo, security review, and implementation estimate.
Integration
Communicates with a DICOM-compatible imaging archive such as PACS to receive MRI input and return BoneMRI images; regular DICOM viewing software displays the result, while receipt and delivery depend on other software systems.
FDA source Exact FDA submission Checked 2026-09-07
Server application on clinic or hospital networks, available fully on premises with specific GPU requirements or partly as a managed cloud service. The FDA summary states that on-premise PHI stays within the network and data sent to the managed cloud is de-identified before leaving it.
FDA source Exact FDA submission Checked 2026-09-07
Deployment language is from the exact FDA submission; it does not establish a current contracted hosting or security configuration.
Vendor confirmation Exact FDA submission Checked 2026-09-07
The FDA deployment description does not establish formal security controls for a current installed configuration.
Training and support
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-08-13
Training, onboarding, competency, and support commitments are commercial implementation details that require current vendor documentation.
Monitoring and change control
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-08-13
Local acceptance testing, production monitoring, drift review, update control, and incident escalation require a current vendor and site-specific governance plan.
Exact deployment and DICOM/PACS path
The FDA summary describes on-premise or partly managed-cloud server deployment and DICOM archive/PACS input and return, with output viewed in regular DICOM software.
MRIguidance's current BoneMRI family page describes 3D CT-like images reconstructed from MRI, forwarding reconstructed images to PACS, and compatibility with major MRI scanners.
product family · checked 2026-09-07
Current family material is buyer-relevant workflow context but does not establish feature parity or release identity for K233030.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.
Evidence summary
K233030 BoneMRI was validated with paired BoneMRI and CT images from 76 pelvic and 117 spine patients. The FDA summary reports bounds for morphology and radiodensity agreement, not exact aggregate point estimates.
FDA source Exact FDA submission Checked 2026-09-07
Needs research Exact FDA submission Checked 2026-08-31
This field has not been curated yet.
Reported specificity
Research pending
Needs research Exact FDA submission Checked 2026-08-31
This field has not been curated yet.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
Quantitative validation using paired BoneMRI and CT images from previously conducted clinical investigations; test data were unseen during development. · 76 patients with pelvic-region data and 117 patients with spine-region data.
exact submission · Tested version: BoneMRI release reviewed in FDA submission K233030 · n=193 · Independence not established
K233030
Validation was conducted by MRIguidance; independent-investigator status was not established.
These are common procurement questions; unknown values remain visible until a source supports them.
Pricing and total cost
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-07
No public exact-submission price or procurement terms were reviewed.
Reimbursement and coding
Research pending
Needs research Exact FDA submission Checked 2026-09-07
CMS policy research was not performed by this worker; no coverage conclusion is made.
Safety and lifecycle
Postmarket record
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-04
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Buyer worksheet
Open questions to take to the vendor
Verify security and privacy controls: The FDA deployment description does not establish formal security controls for a current installed configuration.
Verify training: Training, onboarding, competency, and support commitments are commercial implementation details that require current vendor documentation.
Verify pricing and total cost: No public exact-submission price or procurement terms were reviewed.
Verify reimbursement and coding relevance: CMS policy research was not performed by this worker; no coverage conclusion is made.
Verify local validation and lifecycle monitoring: Local acceptance testing, production monitoring, drift review, update control, and incident escalation require a current vendor and site-specific governance plan.
Verify recalls and postmarket safety signals: No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-07Last searched
24Fields reviewed
11Source classes checked
18Reviewed PubMed leads
2Reviewed trial leads
0Unreviewed FDA recall leads
The stored PubMed and ClinicalTrials candidate metadata were screened in the exact stored order; this was metadata triage, not full-text paper or registry-record review, and no candidate was promoted. The stored recall query returned no records, so no event was promoted and no absence claim is made. The current discovery snapshot contains 18 PubMed and 2 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, literature index, trial registry, stored candidate metadata, stored recall candidates, pubmed, clinical trials, openfda device recall
RemedyLogic AI MRI Lumbar Spine Reader (“RAI”) is an image post-processing and measurement software tool that provides quantitative spine measurements from previously-acquired...
MRI-based BoneMRI v1.6 image enhancement for visualizing pelvic and L3-S1 lumbar bone structures with enhanced contrast; not for tumor diagnosis or monitoring and not a CT...
CoLumbo is an image post-processing and measurement software tool that provides quantitative spine measurements from previously-acquired DICOM lumbar spine Magnetic Resonance (MR)...